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Locke: Angles of Attack: Fighting Cancer with Interdisciplinary Science

Angles OF

ATTACK
This micro-CT image shows a
whole breast tumor on the left,
and the tumor’s microenvironment
with diminished blood vessels and
chemo- and radiation therapyresistant regions on the right.
See page 18 to read more about
research focused on the tumor
microenvironment. (Image credit:
Brad Behnke)
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Fighting cancer with
interdisciplinary science
By Marcia Locke

How do tumors develop despite the body’s defenses? Why can the body stop some tumors
from forming but not others? What makes cancerous cells live longer than normal cells and
wreak havoc on the body? And how can we fight these processes?
Kansas State University researchers are searching for answers to these questions and more
through the interdisciplinary Johnson Cancer Research Center in the College of Arts and
Sciences.
The center’s faculty members span 20 departments in five colleges. They work to
better understand cancer and find ways to prevent it, detect it earlier and treat it more
successfully, while also training the next generation of scientists.
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HELPING THE BODY FIGHT BREAST
CANCER
The body’s immune system helps fight infections and
diseases, including cancers. But cancerous cells can escape
or evade the immune attack and develop into tumors.
Immunotherapy treatment can boost the immune system
so that it can find and attack cancer cells.
Anna Zolkiewska, professor of biochemistry and
molecular biophysics in the College of Arts and Sciences,
is developing and improving immunotherapies for breast
cancer. She studies immune cells that infiltrate and help
destroy breast cancer cells. Her research is supported
by more than $1.65 million from the National Cancer
Institute and more than $300,000 from the Johnson
Cancer Research Center with support from the Flossie E.
West Memorial Trust.
Immunotherapies are very effective against some types
of cancer but are less successful against breast tumors.
Triple-negative breast cancer, a particularly aggressive
form of the disease, is especially hard to treat with
any method. A new immunotherapy called immune
checkpoint blockade offers hope, but it is effective for
only a portion of patients. Zolkiewska is getting closer to
finding out why.
She has discovered that a cell-surface protein called
ADAM12 is important in triple-negative breast cancers.
When she disabled the ADAM12 gene, tumor growth
slowed down. Most importantly, tumors lacking
ADAM12 contained more cancer-fighting immune cells,
especially T cells and B cells.
Zolkiewska also showed that eliminating ADAM12
in breast cancer cells made tumors more responsive to
immune checkpoint blockade therapy. This clue could
improve immunotherapy efficacy for more patients, but
there is evidence that the response may be temporary
and followed by acquired resistance. Zolkiewska plans
to investigate this effect further. She also is exploring if
other proteins from the ADAM family may play a role in
recruiting immune cells to breast tumors.

Photos on left: Anna Zolkiewska, professor of
biochemistry and molecular biophysics, is developing
immunotherapies to treat breast cancer. She has
discovered that a protein important to some breast
cancers can be disabled to slow tumor growth.
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SEEKING ANSWERS IN THE
TUMOR’S ENVIRONMENT
Some researchers are seeking clues from the tumor’s
environment to improve cancer therapies. The Johnson
Cancer Research Center has established the Cancer
Research Collaboration of Excellence in Tumor
Microenvironment Studies.
Brad Behnke, professor of kinesiology and associate
dean of research and graduate studies for the
College of Health and Human Sciences, is leading
the multidisciplinary collaboration. The members’
synergistic investigations examine how environmental
conditions within tumors affect their development,
growth and aggressiveness.
“Many conventional cancer therapies fail due to factors
related to the tumor’s microenvironment,” Behnke said.
“We want to identify microenvironment changes that
cause cancer growth and therapy resistance, and devise
methods to combat them.”
Other researchers involved are Amir Bahadori,
associate professor in the Alan Levin Department
of Mechanical and Nuclear Engineering in the Carl
R. Ice College of Engineering; Carl Ade, associate
professor of kinesiology in the College of Health and
Human Sciences; David Poole, university distinguished
professor of kinesiology in the College of Health and
Human Sciences and of anatomy and physiology in
the College of Veterinary Medicine; Chieko Azuma,
clinical associate professor of radiation oncology in
the College of Veterinary Medicine; and Wei-Wen Hsu,
associate professor of statistics in the College of Arts
and Sciences.
These esteemed experts have received individual
research support from the National Institutes of Health,
NASA, the American Cancer Society, the American
Heart Association and additional organizations. Now
they are teaming up to discover the changes that occur
in the tumor microenvironment when it is exposed
to different levels of radiation, oxygen pressures and
vitamin D. They seek answers to four main questions.
What DNA mutations occur in response to low-dose
radiation?
Low-level radiation exposure can cause DNA
mutations that can develop into cancer. Exposure

Photos on left: Brad Behnke, professor of kinesiology,
top and middle left photos, studies manipulation of
tumor oxygenation to improve cancer therapies.
Carl Ade, associate professor of kinesiology, middle
right and bottom photos, researches cardiovascular
damage caused by cancer treatments.
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occurs in cancer patients undergoing
radiation therapy as well as in
radiation workers, astronauts and
victims of radioactive material
releases. The researchers are
examining the biological mechanisms
involved in such mutations and trying
to develop therapeutics to stop them.
Does exercise increase oxygen in
breast tumors and improve the
response to radiation therapy?
Tumors contain regions of hypoxic
cells, which means they have low
oxygen levels or pressures. This
makes them resistant to radiation
therapy. Aerobic exercise may
increase a tumor’s blood circulation
and oxygen levels and make it more
susceptible to radiation therapy. This
research will determine if aerobic
exercise decreases breast tumor
hypoxia and makes radiation therapy
more effective.
Does nitrate supplementation
increase tumor oxygenation and
decrease tumor growth?
Another strategy to reduce tumor
hypoxia might be to consume foods
or supplements that elevate nitric
oxide bioavailability. Beetroot juice is
a concentrated source of nitrate and
nitrite that is known to increase blood
flow to some tissues. The researchers
will determine if consuming beetroot
juice raises tumor oxygen pressures,
which could slow tumor growth and
improve radiation therapy.
How do ovarian tumors respond to
different levels of vitamin D?
Previous studies have shown that
low levels of vitamin D in ovarian
cancer patients are associated with
larger tumors and lower survival
rates. The scientists will determine
if circulating vitamin D modifies
the tumor microenvironment, and
if so, how. The research could help
predict ovarian cancer treatment
complications, completion and
overall survival.
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TRAINING THE NEXT
GENERATION
K-State excels at getting students involved
in research. A major university goal is to
develop highly skilled citizens who can
advance the well-being of Kansas, the nation
and the world. The Johnson Cancer Research
Center helps achieve that goal by investing in
student research training.
Through the center’s competitive Cancer
Research Award program undergraduate
students receive faculty-mentored research
experiences and monetary awards. Graduate
students receive support for their summertime
research endeavors.
In 2021, 27 undergraduate students received
Cancer Research Awards. Some of their
research projects include:
Studying lung cancer cell
growth.

ATTACKING A KILLER VIRUS
Developing safer methods to
deliver drugs in the body.

Human papillomavirus, or HPV, causes nearly all cervical
cancers — more than half a million worldwide each year.
But many people don’t know that most humans get HPV
at some point in their lives and that it can cause cancers of
both men’s and women’s genitals as well as the throat, skin
and other body parts.

Characterizing genetic
mutations.

Nicholas Wallace, associate professor of biology in the
College of Arts and Sciences, wants to reduce the suffering
caused by HPV by learning more about its biology. He
studies how HPV converts normal cells into factories that
make more of the virus and how this leads to the cells’
uncontrolled and rapid growth — cancer.

Designing inhibitors to
cancer-causing genes.

The awards support research outside
traditional science fields as well. One
student is studying the Navajo approach to
cancer and another is examining the ethical
dimensions of cancer treatment decisions.

“Typically, HPV infections, and the changes associated
with them, are quickly cleared by our immune system,”
Wallace said. “But if the virus escapes the immune system
and the changes become permanent, a tumor will form.
By learning how HPV proteins manipulate cells, we can
determine which cancers were definitely caused by HPV
infection and predict effective treatments.”

The students become integral parts of
research teams and some even publish their
research. Such experience helps K-State
students stand out when applying to graduate
and medical schools, which many awardees
do successfully.

Recently, Wallace’s lab discovered changes in specific genes
that cause commonly used chemotherapies to not work in
some patients. The researchers are using a nearly $455,000
grant from the National Cancer Institute to test a new
drug to treat these chemotherapy-resistant tumors.
Photos above: Nicholas Wallace, associate professor of
biology, studies human papillomavirus, or HPV, which
is a very common virus that causes nearly all cervical
cancers as well as other cancers in men and women.

Seek more
Read more about the Johnson Cancer
Research Center.
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